1. Home
  2. BOF vs CTSO Comparison

BOF vs CTSO Comparison

Compare BOF & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BranchOut Food Inc.

BOF

BranchOut Food Inc.

HOLD

Current Price

$4.04

Market Cap

43.4M

ML Signal

HOLD

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.69

Market Cap

45.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOF
CTSO
Founded
2017
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Medical/Dental Instruments
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.4M
45.7M
IPO Year
2023
2008

Fundamental Metrics

Financial Performance
Metric
BOF
CTSO
Price
$4.04
$0.69
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$5.38
AVG Volume (30 Days)
87.4K
69.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
42.36
N/A
EPS
N/A
N/A
Revenue
$3,184,018.00
$22,503,908.00
Revenue This Year
N/A
$7.29
Revenue Next Year
N/A
$8.91
P/E Ratio
N/A
N/A
Revenue Growth
258.20
48.53
52 Week Low
$1.53
$0.60
52 Week High
$4.95
$1.39

Technical Indicators

Market Signals
Indicator
BOF
CTSO
Relative Strength Index (RSI) 57.21 44.69
Support Level $2.85 $0.62
Resistance Level $4.95 $0.74
Average True Range (ATR) 0.31 0.05
MACD -0.03 -0.01
Stochastic Oscillator 44.59 26.35

Price Performance

Historical Comparison
BOF
CTSO

About BOF BranchOut Food Inc.

Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients.

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

Share on Social Networks: